crackdown on glp 1 meds FDA ESCALATES: 30 telehealth companies hit with warning letters for false claims compounded GLP-1 drugs. The agency accuses firms of misleading consumers by implying unapproved compounded versions match FDA-approved medications South Africa's medicines regulator and

S.SilvermanD

Medicaid members will pay a $4 copay for brand-name or generic (non-brand name) drugs including over the counter medicine

A longitudinal clinical study in subjects at increased cardiovascular risk found that 6-month oral supplementation with acetyl-L-carnitine (2 g/day) significantly reduced arterial blood pressure and improved insulin sensitivity in insulin-resistant individuals, with effects progressively waning after treatment withdrawal

In support of their lawsuits, plaintiffs point to a recent study by the European Medicines Agency (EMA) that indicated that the drugs product information should be updated to include warnings of the risk of developing NAION